CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
2.100
-0.060 (-2.78%)
At close: Apr 1, 2025, 4:00 PM
2.233
+0.133 (6.33%)
After-hours: Apr 1, 2025, 4:28 PM EDT
CASI Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for CASI Pharmaceuticals stock has a target of 6.00, which predicts an increase of 185.71% from the current stock price of 2.10.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 15, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for CASI Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $6 | Strong Buy | Maintains | $12 → $6 | +185.71% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +471.43% | Nov 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +376.19% | Aug 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +376.19% | May 22, 2023 |
| BTIG | BTIG | Strong Buy Maintains $21 → $10 | Strong Buy | Maintains | $21 → $10 | +376.19% | Nov 16, 2022 |
Financial Forecast
Revenue This Year
20.19M
from 33.88M
Decreased by -40.40%
Revenue Next Year
47.41M
from 20.19M
Increased by 134.79%
EPS This Year
-2.61
from -2.02
EPS Next Year
-2.17
from -2.61
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 20.8M | 48.8M | 73.9M | |
| Avg | 20.2M | 47.4M | 71.8M | |
| Low | 19.4M | 45.5M | 68.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -38.6% | 141.7% | 55.8% | |
| Avg | -40.4% | 134.8% | 51.4% | |
| Low | -42.7% | 125.6% | 45.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.69 | -2.24 | -1.84 |
| Avg | -2.61 | -2.17 | -1.79 |
| Low | -2.51 | -2.09 | -1.72 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.